Mucosal and systemic HIV-1 Env-specific CD8+ T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector

被引:58
作者
Shata, MT
Reitz, MS
DeVico, AL
Lewis, GK
Hone, DM
机构
[1] Univ Maryland, Inst Biotechnol, Inst Human Virol, Div Vaccine Res, Baltimore, MD 21201 USA
[2] New York Blood Ctr, Lindsley F Kimball Res Inst, Virol Lab, New York, NY 10021 USA
关键词
Salmonella; vaccine; mucosal immunity; human immunodeficiency virus;
D O I
10.1016/S0264-410X(01)00330-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD8(+) T-cell responses provide beneficial antiviral immunity against human immunodeficiency virus 1 (HIV-1). In this study, we show that intragastric vaccination with a Salmonella HIV-1 Env DNA vaccine vector generates Env-specific CD8(+) T-cells, both in mucosal and systemic lymphoid tissue. By contrast, intramuscular vaccination with the Env DNA vaccine alone only induced systemic CD8(+) T-cells. To our knowledge, this is the first report showing both mucosal and systemic CD8(+) T-cell responses following vaccination with a Salmonella vaccine vector. These data suggest that this mode of HIV-1 DNA vaccine delivery will be advantageous over parenterally administered HIV-1 DNA vaccines. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:623 / 629
页数:7
相关论文
共 37 条
[11]   MOLECULAR-CLONING AND CHARACTERIZATION OF THE HTLV-III VIRUS ASSOCIATED WITH AIDS [J].
HAHN, BH ;
SHAW, GM ;
ARYA, SK ;
POPOVIC, M ;
GALLO, RC ;
WONGSTAAL, F .
NATURE, 1984, 312 (5990) :166-169
[12]   Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS [J].
Hanke, T ;
McMichael, A .
IMMUNOLOGY LETTERS, 1999, 66 (1-3) :177-181
[13]   Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime [J].
Hanke, T ;
Neumann, VC ;
Blanchard, TJ ;
Sweeney, P ;
Hill, AVS ;
Smith, GL ;
McMichael, A .
VACCINE, 1999, 17 (06) :589-596
[14]   Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection [J].
Harrer, T ;
Harrer, E ;
Kalams, SA ;
Elbeik, T ;
Staprans, SI ;
Feinberg, MB ;
Cao, YZ ;
Ho, DD ;
Yilma, T ;
Caliendo, AM ;
Johnson, RP ;
Buchbinder, SP ;
Walker, BD .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (07) :585-592
[15]  
Herremans TMPT, 1999, J IMMUNOL, V162, P5011
[16]   AROMATIC-DEPENDENT SALMONELLA-TYPHIMURIUM ARE NON-VIRULENT AND EFFECTIVE AS LIVE VACCINES [J].
HOISETH, SK ;
STOCKER, BAD .
NATURE, 1981, 291 (5812) :238-239
[17]   CONSTRUCTION OF GENETICALLY DEFINED DOUBLE ARO MUTANTS OF SALMONELLA-TYPHI [J].
HONE, DM ;
HARRIS, AM ;
CHATFIELD, S ;
DOUGAN, G ;
LEVINE, MM .
VACCINE, 1991, 9 (11) :810-816
[18]   SUPPRESSION OF HIV REPLICATION BY CD8(+) CELL CLONES DERIVED FROM HIV-INFECTED AND UNINFECTED INDIVIDUALS [J].
HSUEH, FW ;
WALKER, CM ;
BLACKBOURN, DJ ;
LEVY, JA .
CELLULAR IMMUNOLOGY, 1994, 159 (02) :271-279
[19]   Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus [J].
Kent, SJ ;
Zhao, A ;
Best, SJ ;
Chandler, JD ;
Boyle, DB ;
Ramshaw, IA .
JOURNAL OF VIROLOGY, 1998, 72 (12) :10180-10188
[20]  
KOUP RA, 1989, BLOOD, V73, P1909